NexturnBioscience Co. Ltd (089140) — Cash Flow Quality Index
NexturnBioscience Co. Ltd (089140) has a Cash Flow Quality Index of 11.02x as of September 2025. Operating cash flow of ₩4.51 Billion exceeds net income of ₩409.51 Million, indicating high earnings quality where cash backs reported profits. Explore 089140 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NexturnBioscience Co. Ltd Cash Flow Quality Index (2007–2023)
Historical Cash Flow Quality Index for NexturnBioscience Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 089140 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for NexturnBioscience Co. Ltd (2007–2023)
Year-by-year earnings quality comparison for NexturnBioscience Co. Ltd. For live market cap and the full company financial profile, see market value of NexturnBioscience Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.20x | ₩-1.97 Billion | ₩9.68 Billion | ▼ -142.8% |
| 2019 | 0.48x | ₩2.74 Billion | ₩5.76 Billion | ▼ -72.6% |
| 2018 | 1.73x | ₩9.63 Billion | ₩5.55 Billion | ▲ +131.4% |
| 2017 | 0.75x | ₩5.08 Billion | ₩6.78 Billion | ▼ -7.5% |
| 2016 | 0.81x | ₩17.88 Billion | ₩22.05 Billion | ▼ -42.4% |
| 2015 | 1.41x | ₩1.92 Billion | ₩1.36 Billion | ▼ -11.4% |
| 2014 | 1.59x | ₩6.48 Billion | ₩4.08 Billion | ▲ +1584.5% |
| 2010 | 0.09x | ₩235.94 Million | ₩2.50 Billion | ▼ -89.6% |
| 2009 | 0.91x | ₩998.03 Million | ₩1.10 Billion | ▲ +98.4% |
| 2008 | 0.46x | ₩945.34 Million | ₩2.06 Billion | ▼ -45.0% |
| 2007 | 0.83x | ₩2.26 Billion | ₩2.71 Billion | — |